OPOSTAF Trademark

Trademark Overview

On Monday, January 22, 2007, a trademark application was filed for OPOSTAF with the United States Patent and Trademark Office. The USPTO has given the OPOSTAF trademark a serial number of 79035543. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Sunday, January 22, 2017. This trademark is owned by Astellas Pharma Inc.. The OPOSTAF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances; antibiotic preparations and substances for human
opostaf

General Information

Serial Number79035543
Word MarkOPOSTAF
Filing DateMonday, January 22, 2007
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateSunday, January 22, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances; antibiotic preparations and substances for human

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, January 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, August 18, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, August 17, 2017DEATH OF INTERNATIONAL REGISTRATION
Thursday, November 24, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 26, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 15, 2013CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, July 13, 2013CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 31, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, January 22, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 8, 2008FINAL DISPOSITION NOTICE SENT TO IB
Saturday, December 6, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 25, 2008NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, September 11, 2008NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, September 11, 2008NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, December 6, 2007ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, December 6, 2007ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 24, 2007REFUSAL PROCESSED BY IB
Thursday, May 10, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 10, 2007REFUSAL PROCESSED BY MPU
Thursday, May 10, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 9, 2007NON-FINAL ACTION WRITTEN
Wednesday, May 9, 2007ASSIGNED TO EXAMINER
Thursday, April 5, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, April 5, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

opostaf preparations substances human antibiotic pharmaceutical